Over the past few years the Trust has generously supported a number of cutting-edge research projects at The Institute of Cancer Research, with awards totalling more than £1 million. These projects have ranged from supporting experienced scientists to develop individualised therapies by recognising that cancer cells work in different ways, to funding the next generation of cancer researchers through their PhD projects.
Anthony Sykes, CEO of the Oracle Cancer Trust, knows first hand how challenging a diagnosis of cancer can be. Anthony underwent surgery to remove a tonsillar tumour, followed by an intense treatment phase, including chemotherapy and daily radiotherapy. Through the improvements made by ICR scientists to the delivery of radiotherapy and the expert care of oncologists at The Royal Marsden NHS Foundation Trust, Anthony has now made a full recovery. His particular experience demonstrates the crucial importance of cancer research.
Anthony says: “Through the Oracle Cancer Trust we want to continue supporting pioneering approaches to cancer research which will go on to form the blueprint for the development of national clinical studies in order to significantly improve the quality of life for head and neck cancer patients.”